Regulation of the Neurotensin NT(1) Receptor in the Developing Rat Brain Following Chronic Treatment with the Antagonist SR 48692

Overview

Journal J Neurosci Res

Specialty Neurology

Date 2000 May 8

PMID 10797539

Citations 2

Authors

C Betancur

F Souaze

W Rostene

A Berod

D Pelaprat

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the role of neurotensin in the regulation of NT(1) receptors during postnatal development in the rat brain. Characterization of the ontogeny of neurotensin concentration and [(125)I]neurotensin binding to NT(1) receptors in the brain at different embryonic and postnatal stages showed that neurotensin was highly expressed at birth, reaching peak levels at postnatal day 5 (P5) and decreasing thereafter. The transient rise in neurotensin levels preceded the maximal expression of NT(1) receptors, observed at P10, suggesting that neurotensin may influence the developmental profile of NT(1) receptors. Using primary cultures of cerebral cortex neurons from fetal rats, we showed that exposure to the neurotensin agonist JMV 449 (1 nM) decreased (-43%) the amount of NT(1) receptor mRNA measured by reverse transcription-PCR, an effect that was abolished by the nonpeptide NT(1) receptor antagonist SR 48692 (1 microM). However, daily injection of SR 48692 to rat pups from birth for 5, 9, or 15 days did not modify [(125)I]neurotensin binding in brain membrane homogenates. Moreover, postnatal blockade of neurotensin transmission did not alter the density and distribution of NT(1) receptors assessed by quantitative autoradiography nor NT(1) receptor mRNA expression measured by in situ hybridization in the cerebral cortex, caudate-putamen, and midbrain. These results suggest that although NT(1) receptor expression can be regulated in vitro by the agonist at an early developmental stage, neurotensin is not a major factor in the establishment of the ontogenetic pattern of NT receptors in the rat brain.

Citing Articles

Developmental dynamics of neurotensin binding sites in the human hypothalamus during the first postnatal year.

Najimi M, Sarrieau A, Kopp N, Chigr F Front Cell Neurosci. 2014; 8:251.

PMID: 25309316 PMC: 4160091. DOI: 10.3389/fncel.2014.00251.

High-affinity neurotensin receptor is involved in phosphoinositide turnover increase by inhibition of sodium pump in neonatal rat brain.

Pereyra-Alfonso S, Del Valle Armanino M, Vazquez C, Pena C, Rodriguez de Lores Arnaiz G Neurochem Res. 2008; 33(11):2206-13.

PMID: 18758956 DOI: 10.1007/s11064-008-9672-2.

References

Najimi M, Souaze F, Mendez M, Hermans E, Berbar T, Rostene W . Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure. Study on neurotensin receptor. J Biol Chem. 1998; 273(34):21634-41. DOI: 10.1074/jbc.273.34.21634. View

Ehlers 2nd R, Bonnor R, Wang X, Hellmich M, Evers B . Signal transduction mechanisms in neurotensin-mediated cellular regulation. Surgery. 1998; 124(2):239-46; discussion 246-7. View

Hermans E, Maloteaux J . Mechanisms of regulation of neurotensin receptors. Pharmacol Ther. 1998; 79(2):89-104. DOI: 10.1016/s0163-7258(98)00009-6. View

Mazella J, Zsurger N, Navarro V, Chabry J, Kaghad M, Caput D . The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem. 1998; 273(41):26273-6. DOI: 10.1074/jbc.273.41.26273. View

Bennett G, Moss S, Forster C, Marsden C . Developmental changes in neurotensin and its metabolites in the neonatal rat. Brain Res Dev Brain Res. 1998; 111(2):189-96. DOI: 10.1016/s0165-3806(98)00137-0. View

Dubuc I, Sarret P, Labbe-Jullie C, Botto J, Honore E, Bourdel E . Identification of the receptor subtype involved in the analgesic effect of neurotensin. J Neurosci. 1998; 19(1):503-10. PMC: 6782393. View

Betancur C, Rostene W, Pelaprat D . Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization. Brain Res Dev Brain Res. 1999; 113(1-2):115-31. DOI: 10.1016/s0165-3806(99)00009-7. View

Cheng Y, Prusoff W . Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973; 22(23):3099-108. DOI: 10.1016/0006-2952(73)90196-2. View

Munson P, Rodbard D . Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980; 107(1):220-39. DOI: 10.1016/0003-2697(80)90515-1. View

10.

Hara Y, Shiosaka S, Senba E, Sakanaka M, Inagaki S, Takagi H . Ontogeny of the neurotensin-containing neuron system of the rat: immunohistochemical analysis. I. Forebrain and diencephalon. J Comp Neurol. 1982; 208(2):177-95. DOI: 10.1002/cne.902080207. View

11.

Bissette G, Richardson C, Kizer J, Nemeroff C . Ontogeny of brain neurotensin in the rat: a radioimmunoassay study. J Neurochem. 1984; 43(1):283-7. DOI: 10.1111/j.1471-4159.1984.tb06711.x. View

12.

SCHOTTE A, Leysen J, Laduron P . Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1986; 333(4):400-5. DOI: 10.1007/BF00500016. View

13.

SCHOTTE A, Laduron P . Different postnatal ontogeny of two [3H]neurotensin binding sites in rat brain. Brain Res. 1987; 408(1-2):326-8. DOI: 10.1016/0006-8993(87)90398-2. View

14.

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

15.

Palacios J, Pazos A, Dietl M, Schlumpf M, Lichtensteiger W . The ontogeny of brain neurotensin receptors studied by autoradiography. Neuroscience. 1988; 25(1):307-17. DOI: 10.1016/0306-4522(88)90028-0. View

16.

Parnavelas J, Cavanagh M . Transient expression of neurotransmitters in the developing neocortex. Trends Neurosci. 1988; 11(3):92-3. DOI: 10.1016/0166-2236(88)90150-6. View

17.

Pelaprat D, Dusart I, Peschanski M . Postnatal development of cholecystokinin (CCK) binding sites in the rat forebrain and midbrain: an autoradiographic study. Brain Res Dev Brain Res. 1988; 44(1):119-32. DOI: 10.1016/0165-3806(88)90123-x. View

18.

Alexander M, Miller M, Dorsa D, Bullock B, Melloni Jr R, Dobner P . Distribution of neurotensin/neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum. Proc Natl Acad Sci U S A. 1989; 86(13):5202-6. PMC: 297586. DOI: 10.1073/pnas.86.13.5202. View

19.

Tanaka K, Masu M, Nakanishi S . Structure and functional expression of the cloned rat neurotensin receptor. Neuron. 1990; 4(6):847-54. DOI: 10.1016/0896-6273(90)90137-5. View

20.

Tribollet E, Goumaz M, Raggenbass M, Dubois-Dauphin M, Dreifuss J . Early appearance and transient expression of vasopressin receptors in the brain of rat fetus and infant. An autoradiographical and electrophysiological study. Brain Res Dev Brain Res. 1991; 58(1):13-24. DOI: 10.1016/0165-3806(91)90232-8. View